Christopher Paul Simms serves as Executive at IVERIC bio, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Paul Simms has executed 8 insider transactions totaling $235.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 11, 2023 involved selling 32,429 shares valued at $0.
Christopher Paul Simms currently holds 32,429 shares of IVERIC bio, Inc. (ISEE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Paul Simms has been a net seller of ISEE stock. They have purchased $50.0K and sold $185.6K worth of shares.
Christopher Paul Simms's most recent insider trade was on Jul 11, 2023, when they sold 32,429 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $20.06 |
| Discretionary |
| Jan 2, 2023 | ISEE | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Aug 3, 2022 | ISEE | $76.7K | Sale | 6,818 | $11.25 | Discretionary |
| Aug 3, 2022 | ISEE | $61.4K | Sale | 5,454 | $11.25 | Discretionary |
| Aug 2, 2022 | ISEE | $0 | Option Exercise | 15,000 | $N/A | Discretionary |
| Aug 2, 2022 | ISEE | $0 | Option Exercise | 18,750 | $N/A | Discretionary |
| Nov 18, 2021 | ISEE | $50.0K | Purchase | 3,069 | $16.30 | Discretionary |